G

Gelteq Ltd
NASDAQ:GELS

Watchlist Manager
Gelteq Ltd
NASDAQ:GELS
Watchlist
Price: 0.855 USD 3.02% Market Closed
Market Cap: 9.2m USD

Gelteq Ltd
EPS (Diluted)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Gelteq Ltd
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
G
Gelteq Ltd
NASDAQ:GELS
EPS (Diluted)
AU$0
CAGR 3-Years
-25%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Mayne Pharma Group Ltd
ASX:MYX
EPS (Diluted)
-AU$1
CAGR 3-Years
30%
CAGR 5-Years
1%
CAGR 10-Years
N/A
Neuren Pharmaceuticals Ltd
ASX:NEU
EPS (Diluted)
AU$1
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Botanix Pharmaceuticals Ltd
ASX:BOT
EPS (Diluted)
AU$0
CAGR 3-Years
-71%
CAGR 5-Years
-20%
CAGR 10-Years
-17%
C
Clarity Pharmaceuticals Ltd
ASX:CU6
EPS (Diluted)
AU$0
CAGR 3-Years
-26%
CAGR 5-Years
-46%
CAGR 10-Years
N/A
Nyrada Inc
ASX:NYR
EPS (Diluted)
AU$0
CAGR 3-Years
13%
CAGR 5-Years
17%
CAGR 10-Years
N/A
No Stocks Found

Gelteq Ltd
Glance View

Market Cap
9.2m USD
Industry
Pharmaceuticals

Gelteq Ltd is a AU-based company operating in Pharmaceuticals industry. The company is headquartered in Melbourne, Victoria. The company went IPO on 2024-10-29. Gelteq Limited is an Australia-based clinical and science-based company. The firm is focused on developing and commercializing white-label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products. The firm offers a complete end-to-end service for the development of new products and the conversion of existing products and formulations into gels. Its product suite consists of multiple products that sit within five core verticals - for pets, sports, pharmaceuticals (pharma), over-the-counter (OTC) and nutraceuticals. The Company’s delivery system provides pharma and nutraceutical enhancements throughout every stage of ingestion in both animals and humans, addressing the complete experience from the point of ingestion to final absorption. The firm also offers a highly versatile portfolio of pre-tested and market-ready proprietary formulations that can be white-labelled.

GELS Intrinsic Value
0.046 USD
Overvaluation 95%
Intrinsic Value
Price
G

See Also

What is Gelteq Ltd's EPS (Diluted)?
EPS (Diluted)
-0.7 AUD

Based on the financial report for Jun 30, 2025, Gelteq Ltd's EPS (Diluted) amounts to -0.7 AUD.

What is Gelteq Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 3Y
-25%

Over the last year, the EPS (Diluted) growth was -84%. The average annual EPS (Diluted) growth rates for Gelteq Ltd have been -25% over the past three years .

Back to Top